1. Home
  2. STOK vs OPRA Comparison

STOK vs OPRA Comparison

Compare STOK & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

N/A

Current Price

$26.13

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Opera Limited

OPRA

Opera Limited

N/A

Current Price

$17.73

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
STOK
OPRA
Founded
2014
1996
Country
United States
Norway
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
STOK
OPRA
Price
$26.13
$17.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
6
Target Price
★ $46.46
$26.29
AVG Volume (30 Days)
★ 638.1K
288.6K
Earning Date
11-03-2026
10-28-2026
Dividend Yield
N/A
★ 4.54%
EPS Growth
★ 92.73
N/A
EPS
N/A
★ N/A
Revenue
★ $184,420,000.00
N/A
Revenue This Year
N/A
$20.36
Revenue Next Year
$39.98
$15.27
P/E Ratio
★ N/A
$13.62
Revenue Growth
★ 404.50
N/A
52 Week Low
$20.32
$11.71
52 Week High
$40.22
$20.78

Technical Indicators

Market Signals
Indicator
STOK
OPRA
Relative Strength Index (RSI) 38.05 38.89
Support Level $25.21 $17.39
Resistance Level $33.92 $19.43
Average True Range (ATR) 1.15 0.42
MACD -0.17 -0.02
Stochastic Oscillator 36.31 32.26

Price Performance

Historical Comparison
STOK
OPRA

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About OPRA Opera Limited

Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.

Share on Social Networks: